IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
17 hedge funds and large institutions have $1.04M invested in ImmunoCellular Therapeutics, Ltd. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$50.1K | |
| 2 | +$1.75K | |
| 3 | +$337 | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$248 |
| 5 |
Morgan Stanley
New York
|
+$144 |
Top Sellers
| 1 | -$52.8K | |
| 2 | -$13.1K | |
| 3 | -$3.1K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$65 |